Study of SPG302 in Healthy Volunteers and ALS Participants

Clinical trial NCT05882695 · COMPLETED

Trial details

NCT number: NCT05882695
Sponsor: Spinogenix
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2023-07-03
Primary completion: 2025-06-27
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.